Contact Us    855-RIA-PLAN (855-742-7526)

AMRX: Amneal Pharmaceuticals Inc Stock

By | July 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 672.17
Enterprise Value ($M) 3,102.92
Book Value ($M) 398.43
Book Value / Share 2.67
Price / Book 1.69
NCAV ($M) -2,005.65
NCAV / Share -13.43
Price / NCAV -0.34

Profitability (mra)
Return on Invested Capital (ROIC) 0.00
Return on Assets (ROA) 0.00
Return on Equity (ROE) 0.04

Liquidity (mrq)
Quick Ratio 1.57
Current Ratio 2.35

Balance Sheet (mrq) ($M)
Current Assets 1,570.34
Assets 3,974.41
Liabilities 3,575.98
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-12 13G/A Wellington Management Group Llp 0.04 -99.61
02-10 13G/A BlackRock Inc. 4.97 -0.86
02-10 13G/A Vanguard Group Inc 7.44 7.83

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT
2021-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO S
2021-05-07 10-Q Quarterly Report – 10-Q
2021-03-01 10-K Annual Report – 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-01-18 58,563 425,726 13.76
2022-01-13 47,445 395,356 12.00

(click for more detail)

(click for list of largest short owners)

Similar Companies
ABT – Abbott Laboratories ADCT – Adc Telecommunications Inc
AMAM – Ambrx Biopharma Inc. (each representing seven ) BHC – BauschHealth?Companies?Inc.
BHVN – Biohaven Pharmaceutical Holding Co Ltd


Financial data and stock pages provided by
Fintel.io





2018/07/06
> Back to All Posts